JPMORGAN CHASE & CO - GLOBUS MED INC ownership

GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 362 filers reported holding GLOBUS MED INC in Q2 2022. The put-call ratio across all filers is 0.16 and the average weighting 0.1%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of GLOBUS MED INC
ValueSharesWeighting
Q3 2023$105,847,274
-6.4%
2,131,868
+12.2%
0.01%0.0%
Q2 2023$113,131,668
+8.7%
1,900,095
+3.4%
0.01%
-7.7%
Q1 2023$104,072,799
+104564.2%
1,837,425
+37.2%
0.01%0.0%
Q4 2022$99,435
-99.9%
1,338,833
-0.1%
0.01%
+18.2%
Q3 2022$79,831,000
+462.2%
1,340,112
+429.8%
0.01%
+450.0%
Q2 2022$14,199,000
-8.3%
252,923
+20.5%
0.00%0.0%
Q1 2022$15,480,000
-4.5%
209,813
-6.5%
0.00%0.0%
Q4 2021$16,205,000
+10.6%
224,453
+17.4%
0.00%0.0%
Q3 2021$14,652,000
+6.2%
191,228
+7.5%
0.00%0.0%
Q2 2021$13,792,000
+39.5%
177,892
+10.9%
0.00%
+100.0%
Q1 2021$9,890,000
-4.4%
160,362
+1.1%
0.00%
-50.0%
Q4 2020$10,347,000
+99.6%
158,643
+49.7%
0.00%
+100.0%
Q3 2020$5,184,000
-5.7%
106,007
-8.0%
0.00%0.0%
Q2 2020$5,496,000
-76.5%
115,180
-79.0%
0.00%
-80.0%
Q1 2020$23,373,000
+21.4%
549,557
+68.1%
0.01%
+25.0%
Q4 2019$19,253,000
+53.6%
326,976
+33.3%
0.00%
+100.0%
Q3 2019$12,536,000
+53.8%
245,226
+28.3%
0.00%0.0%
Q2 2019$8,151,000
+8.9%
191,136
+26.1%
0.00%0.0%
Q1 2019$7,488,000
-56.3%
151,554
-61.7%
0.00%
-50.0%
Q4 2018$17,147,000
+59.1%
396,175
+108.6%
0.00%
+100.0%
Q3 2018$10,778,000
-28.3%
189,891
-36.3%
0.00%
-33.3%
Q2 2018$15,034,000
+105.0%
297,934
+102.4%
0.00%
+50.0%
Q1 2018$7,334,000
+164.6%
147,222
+118.3%
0.00%
+100.0%
Q4 2017$2,772,000
+5926.1%
67,430
+4295.7%
0.00%
Q3 2017$46,000
+21.1%
1,534
+33.2%
0.00%
Q2 2017$38,000
+31.0%
1,152
+16.6%
0.00%
Q1 2017$29,000
+31.8%
988
+12.7%
0.00%
Q4 2016$22,000
-73.8%
877
-76.3%
0.00%
Q3 2016$84,000
-57.6%
3,700
-55.6%
0.00%
Q2 2016$198,000
+3860.0%
8,334
+3945.6%
0.00%
Q1 2016$5,0000.0%206
+6.2%
0.00%
Q4 2015$5,000
-99.9%
194
-99.9%
0.00%
-100.0%
Q2 2015$4,020,000
-9.5%
156,574
-11.1%
0.00%0.0%
Q1 2015$4,443,000
-49.4%
176,042
-52.3%
0.00%
-50.0%
Q4 2014$8,775,000
+167.4%
369,163
+121.3%
0.00%
+100.0%
Q3 2014$3,281,000
+906.4%
166,818
+794.3%
0.00%
Q3 2013$326,00018,6530.00%
Other shareholders
GLOBUS MED INC shareholders Q2 2022
NameSharesValueWeighting ↓
Consonance Capital Management LP 589,100$45,137,00024.71%
Sterling Investment Advisors, Ltd. 188,123$14,414,0004.29%
Godshalk Welsh Capital Management, Inc. 73,748$5,651,0003.52%
Pembroke Management, LTD 601,447$46,083,0003.47%
Integral Health Asset Management, LLC 150,000$11,493,0003.30%
XXEC, Inc. 51,925$3,978,0003.03%
PARADIGM CAPITAL MANAGEMENT INC/NY 615,000$47,122,0002.42%
Van Berkom & Associates Inc. 946,997$72,559,0002.20%
RTW INVESTMENTS, LP 1,670,811$128,018,0001.93%
Sivik Global Healthcare LLC 95,000$7,279,0001.74%
View complete list of GLOBUS MED INC shareholders